Industry News

Suprepharmagroup partner plans a RMB 300 million creatine monohydrate project in Inner Mongolia, targeting 50,000 tons of annual capacity.

Peptide therapeutics are gaining importance in the global pharmaceutical industry. Growing demand for chronic disease treatments, patent expiries, advances in peptide synthesis and AI-assisted drug discovery are creating new opportunities for peptide APIs and pharmaceutical raw material suppliers.

The global high-end API market is entering a new phase of quality-led growth. Demand for specialty APIs, HPAPIs and complex pharmaceutical raw materials is increasing, while technology, GMP compliance, supply stability and manufacturing efficiency are becoming key factors in global API competition.

The global GLP-1 peptide raw materials market is entering a new phase of structural development. Rising demand, supply chain restructuring, manufacturing technology, quality control and supply stability are becoming key factors shaping competition across the peptide API industry.

Recent industry research highlights growing interest in 3-Methyl-10-Ethyl-Deazaflavin in China, with potential applications in cosmetics, dietary supplements and pharmaceutical research driven by interest in NAD+ metabolism and healthy aging.